Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-02-26 @ 11:53 PM
Study NCT ID:
NCT00868595
Status:
COMPLETED
Last Update Posted:
2019-10-08
First Post:
2009-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
Sponsor:
Bellicum Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BP-PC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None